tag:www.gov.uk,2005:/drug-device-alertsAlerts, recalls and safety information: medicines and medical devices about GI, hepatology and pancreatic disorders2026-07-30T14:03:00+01:00HM Governmenttag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-july-20262026-07-30T14:03:00+01:00MHRA Safety Roundup: July 2026Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-june-20262026-06-30T14:09:46+01:00MHRA Safety Roundup: June 2026Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-may-20262026-05-28T13:07:24+01:00MHRA Safety Roundup: May 2026Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/allurion-gastric-balloon-updated-safety-information-due-to-the-risks-of-gastric-outlet-obstruction-small-bowel-obstruction-and-gastric-perforation-dsi-slash-2026-slash-0042026-05-27T14:21:45+01:00Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)In rare instances, the Allurion Gastric Balloon has not transited through the stomach or bowel as intended, leading to complications such as gastric outlet obstruction, small bowel obstruction and gastric perforation.
tag:www.gov.uk,2005:/drug-device-alerts/risk-of-severe-harm-from-use-of-incorrect-giving-administration-set-for-blood-transfusion-dsi-slash-2026-slash-0032026-05-20T14:01:11+01:00Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)There is a potential for serious harm to patients if an intravenous (IV) infusion giving set is used instead of a blood transfusion giving set to deliver a transfusion of blood or blood components.tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-april-20262026-04-29T14:02:41+01:00MHRA Safety Roundup: April 2026Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-march-20262026-03-31T14:01:53+01:00MHRA Safety Roundup: March 2026Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-regent-medical-limited-slash-molnlycke-health-care-hibiwash-500ml-el-26-a-slash-152026-03-23T16:32:53+00:00Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15Mölnlycke Health Care are recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring.tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-february-20262026-02-25T11:12:50+00:00MHRA Safety Roundup: February 2026Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspension-unlicensed-medicine-manufactured-by-eaststone-limited-due-to-a-potential-for-overdosing-natpsa-slash-2026-slash-002-slash-mhr2026-01-29T12:13:05+00:00National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing, NatPSA/2026/002/MHRAEaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-december-20252025-12-18T13:55:18+00:00MHRA Safety Roundup: December 2025Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-november-20252025-11-27T14:05:40+00:00MHRA Safety Roundup: November 2025Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-october-20252025-10-28T14:28:26+00:00MHRA Safety Roundup: October 2025Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-september-20252025-09-30T13:59:39+01:00MHRA Safety Roundup: September 2025Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-may-20252025-06-13T15:11:47+01:00MHRA Safety Roundup: May 2025Summary of the latest safety advice for medicines and medical device userstag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-mercaptopurine-50mg-tablets-aspen-pharma-trading-limited-el-25-a-slash-232025-05-22T10:00:25+01:00Class 2 Medicines Recall: Mercaptopurine 50mg Tablets, Aspen Pharma Trading Limited, EL (25)A/23Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to microbial contamination following a small number of complaints of discoloured tablets within the pac…tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-march-20252025-04-08T17:53:02+01:00MHRA Safety Roundup: March 2025Summary of the latest safety advice for medicines and medical device users